
Postpartum Disorders
Latest News
Advertisement
Latest Videos

CME Content
Advertisement
More News

Here’s a look at our recent coverage of these disorders in honor of Mother’s Day 2024.

How can psychiatric clinicians improve outcomes for this unique patient population?

Neurosteroid therapeutics could be the solution to provide fast-acting treatment for mothers with postpartum depression.

The FDA did not grant approval for the treatment for major depressive disorder.

Black mothers in the US experience far worse outcomes. Here’s what clinicians need to know.
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Shelves Fast-Track Drug Review Initiative
2
Schizo-Obsessed! Untangling the Overlap Between Obsessive Compulsive Disorder and Schizophrenia
3
Oveporexton Now Available: First and Only Orexin Agonist for Narcolepsy Type 1
4
New National Guidance for Managing Medetomidine Intoxication and Withdrawal
5












